Effectiveness of the antiseptic barrier cap on rate of bloodstream infections

Effectiveness of the antiseptic barrier cap on rate of bloodstream infections and central line associated bloodstream infections

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26906

Enrollment

1700

Registered

2016-04-20

Start date

2016-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis, central line associated bloodstream infection, infants, children, intensive care

Interventions

An antiseptic barrier cap will be investigated in a NICU and PICU setting, which is developed to improve disinfection procedures and helps to prevent bloodstream infections and CLABSIs by optimizing h

Eligibility

Inclusion criteria

Inclusion criteria: All infants admitted to the Neonatal Intensive Care Unit with peripheral catheter, tunneled and non-tunneled central venous catheters, and/or umbilical catheters. Pediatric Intensive Care Unit all children with a tunneled and non-tunneled central venous catheters, and/or umbilical catheters and combined with a periferal catheter.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Rate of CLABSI per 1.000 central line days	—

Secondary

Measure	Time frame
- Compliance of the Healthcare workers who use the antiseptic barrier cap. - Incidence of bloodstream infections - Costs	—

Contacts

Public ContactOnno K. Helder

Wytemaweg 80

o.helder@erasmusmc.nl+31 (0)10 7037455

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)